8-K current report · filed Sep 1, 2026

Alamar Biosciences Inc (ALMR) 8-K Current Report: September 1, 2026

Item 5.02ALMR overview

Short answer

Alamar Biosciences Inc (ALMR) filed an 8-K current report with the SEC on September 1, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Robert Ragusa appointed Class I director effective September 1, 2026, term expiring at the 2027 Annual Meeting.

Alamar Biosciences Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Robert Ragusa appointed Class I director effective September 1, 2026, term expiring at the 2027 Annual Meeting
  • Board committee assignments span Audit, Compensation, and Nominating and Corporate Governance Committees
  • Appointment expands board oversight across financial reporting, executive pay, and governance matters
  • Director compensation follows the company’s Non-Employee Director Compensation Policy, with standard indemnification terms

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Alamar Biosciences Inc 8-K filings

Get the next ALMR 8-K as it lands

Follow ALMR for push alerts, or ask the research agent what this filing means.